» Articles » PMID: 24011936

Trends in Incidence and Survival of Dutch Women with Vulvar Squamous Cell Carcinoma

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2013 Sep 10
PMID 24011936
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Previous studies showed an increase in incidence of vulvar intraepithelial neoplasia (VIN), the premalignant lesion of Vulvar Squamous Cell Carcinoma (VSCC). Furthermore, during the last decades treatment of VSCC became less radical. Considering these changes the aim of this study was to describe trends of incidence and survival of patients with VSCC in the Netherlands.

Methods: All patients with VSCC diagnosed between 1989 and 2010 (n=4614) were selected from the Netherlands Cancer Registry. Trends in age-adjusted incidence rates were evaluated by calculating the estimated annual percentage change (EAPC). Joinpoint regression analysis was used to detect changes in trends. Five-year relative survival rates were calculated for four time periods.

Results: The incidence of VSCC has increased since 2002 (EAPC 5.0; 95% confidence interval (CI): 2.7-7.7%). In women aged <60years incidence rates increased significantly during the whole study period (EAPC 3.5%; 95% CI: 2.0-4.9), while in women aged ≥ 60 years only an increase has observed from 2004 onwards (EAPC 5.0; 95% CI: 1.5-8.6). Survival rates did not change over time.

Conclusion: The incidence rate of VSCC has increased from 2002 onwards in all women. Over the whole study period the increase was strongest in women aged <60 years. The introduction of less radical surgery did not affect survival.

Citing Articles

Influence of stage and age on survival of patients with vulvar cancer in Germany: a retrospective study.

Mack L, Hagemeier A, Forner D BMJ Open. 2024; 14(8):e077960.

PMID: 39209505 PMC: 11367380. DOI: 10.1136/bmjopen-2023-077960.


Impact of the COVID-19 Pandemic on Tumor Stage and Pathohistological Parameters of Vulvar Cancer.

Klamminger G, Bitterlich A, Nigdelis M, Schnoder L, Haj Hamoud B, Solomayer E J Clin Med. 2024; 13(14).

PMID: 39064099 PMC: 11277637. DOI: 10.3390/jcm13144058.


Changing the paradigm: Elimination - Not only of cervical cancer.

Bornstein J, Sacinti K, Preti M, Billan S, Razeghian H, Stockdale C Gynecol Oncol Rep. 2024; 54:101445.

PMID: 39045263 PMC: 11263942. DOI: 10.1016/j.gore.2024.101445.


Incidence Trends of Vulvar Cancer in the United States: A 20-Year Population-Based Study.

Mousavi S, Ghasemi H, Najafi M, Yekta Z, Nejadghaderi S Cancer Rep (Hoboken). 2024; 7(6):e2120.

PMID: 39031816 PMC: 11190582. DOI: 10.1002/cnr2.2120.


Genomic profiles of Japanese patients with vulvar squamous cell carcinoma.

Fujii E, Kato M, Yamaguchi M, Higuchi D, Koyama T, Komatsu M Sci Rep. 2024; 14(1):13058.

PMID: 38844774 PMC: 11156893. DOI: 10.1038/s41598-024-63913-z.